ClinicalTrials.govpublic full text
SHR0302 Combined With PD-1/PD-L1 Inhibition for Treatment naïve or Acquired Resistant to Immunology NSCLC
non-small cell lung cancer, jak inhibitor, immunology
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 245495
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.